Clostridium perfringens type A–E toxin plasmids Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Microbes
Microbes
Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was reviewed?
This review examined toxin-encoding plasmids in Clostridium perfringens and how they regulate toxin production, virulence, and microbiome adaptation. These plasmids carry genes encoding major toxins such as enterotoxin, NetB, beta toxin, epsilon toxin, and iota toxin, which directly cause intestinal and systemic disease. The review explained that these plasmids contain conjugation machinery that allows toxin genes to transfer between bacterial strains, enabling rapid virulence acquisition. This plasmid-mediated gene transfer allows microbiome commensal strains to become pathogenic when they acquire toxin genes, linking microbiome genetic exchange with infection risk.
Who was reviewed?
The review analyzed toxin-producing Clostridium perfringens strains from human and animal intestinal microbiomes, including both pathogenic and commensal strains. These strains represented multiple toxinotypes that differ based on plasmid-encoded toxin gene content. Some strains carried multiple toxin plasmids, increasing virulence potential. These bacteria exist in the microbiome as colonizers but can become pathogenic after acquiring toxin plasmids through horizontal gene transfer.
What were the most important findings?
The most important finding was that toxin plasmids are the primary determinants of virulence and microbiome pathogenic potential in Clostridium perfringens. Major microbial associations included conjugative plasmid transfer, toxin gene acquisition, and microbiome-driven virulence evolution. Plasmids containing toxin genes transferred between strains using conjugation systems, allowing rapid spread of pathogenic traits. Individual strains could carry multiple toxin plasmids simultaneously, increasing toxin production and disease severity. Toxin gene mobility through insertion sequences enabled continuous genetic reshaping, allowing adaptation to microbiome environmental pressures. These findings demonstrated that toxin production depends on plasmid carriage rather than bacterial species identity alone.
What are the greatest implications of this review?
This review demonstrated that microbiome gene transfer directly controls virulence in Clostridium perfringens by enabling rapid acquisition of toxin genes. Detection of toxin plasmids represents a key microbiome signature of infection risk. These findings identify plasmid transfer mechanisms as critical therapeutic targets for preventing toxin-mediated disease and limiting microbiome-driven pathogen evolution.
Clostridium perfringens
Clostridium perfringens is a fast-growing, Gram-positive, spore-forming anaerobe and a major toxin-mediated pathogen affecting humans and animals. Widely distributed in soil, food, and gastrointestinal microbiota, it causes diseases ranging from food poisoning and antibiotic-associated diarrhoea to life-threatening clostridial myonecrosis. Its pathogenicity is driven by diverse plasmid-encoded toxins, including α-toxin, enterotoxin, and perfringolysin O, while conjugative mobile genetic elements facilitate rapid dissemination of antimicrobial resistance and virulence traits. Genome-informed toxinotyping and molecular surveillance are therefore essential for accurate risk assessment, clinical management, and outbreak control.